CNBX PHARMACEUTICALS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.3M | $3.1M | $1.4M |
| FY2022 | $-821.1K | $811.2K | $117.5K |
| FY2023 | $2.5M | $499.0K | $129.7K |
| FY2024 | $2.5M | $31.4K | $26.4K |
| FY2025 | $2.5M | $18.4K | $15.1K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.3M | $3.1M | $1.4M |
| FY2022 | $-821.1K | $811.2K | $117.5K |
| FY2023 | $2.5M | $499.0K | $129.7K |
| FY2024 | $2.5M | $31.4K | $26.4K |
| FY2025 | $2.5M | $18.4K | $15.1K |